One year into the second Trump administration, we have seen a continuation of some evergreen enforcement priorities as well as new fonts of potential risk and exposure. As in years past, the investigation and prosecution of health care fraud cases remains at the forefront of the federal government’s enforcement activity, though tempered by the government’s interest in a variety of non-health care enforcement, some of which we take up in forthcoming entries in our Year in Preview series.
Enforcement Highlights in 2025
As of the date of publication, the U.S. Department of Justice had not yet released judgment and settlement data in False Claims Act cases, including health care cases. Some charged conduct from 2025, however, provides a glimpse at metrics showing another big year for health care fraud enforcement. In particular, on June 30, 2025, the Justice Department announced the results of the National Health Care Fraud Takedown, charging 324 defendants in connection with over $14.6 billion in alleged fraud. This wide spanning enforcement action was a combined effort of 50 federal districts and 12 state Attorney General’s Offices across the United States. The charges encompassed a broad range of alleged schemes, including kickbacks and bribery arrangements; telemedicine and durable medical equipment billing; opioid distribution and prescription fraud; pharmacy and compounded drug claims; fraudulent wound care services; home health and hospice billing telemedicine; and...
0APT is a ransomware operation first identified in late January 2026 that immediately gained attention by claiming hundreds of victims within its first 48 hours of observed activity. New Halcyon a...